IGF2BP2 and neoplasm: Meanwhile, FTO inhibits the expression of APOE via IGF2BP2-mediated m6A modification and regulates IL-6/JAK2/STAT3 signaling pathway to inhibit the glycolytic metabolism of PTC, thereby repressing tumor growth (79).